4-Pyrimidinecarboxamide, N-[(4-fluorophenyl-2,3,5,6-d4)methyl-d2]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-
| 中文名稱 | 4-Pyrimidinecarboxamide, N-[(4-fluorophenyl-2,3,5,6-d4)methyl-d2]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo- |
|---|---|
| 中文同義詞 | [2H6]-雷特格韋;雷特格韋-[D6];2H6]-拉替拉韋;雷特格韋-[d6] (標(biāo)準(zhǔn)品) |
| 英文名稱 | 4-Pyrimidinecarboxamide, N-[(4-fluorophenyl-2,3,5,6-d4)methyl-d2]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo- |
| 英文同義詞 | 4-Pyrimidinecarboxamide, N-[(4-fluorophenyl-2,3,5,6-d4)methyl-d2]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-;Raltegravir-[D6] (Standard) |
| CAS號(hào) | 1100750-98-8 |
| 分子式 | C20H15D6FN6O5 |
| 分子量 | 450.453313868 |
| EINECS號(hào) | |
| 相關(guān)類別 | |
| Mol文件 | 1100750-98-8.mol |
| 結(jié)構(gòu)式 | ![]() |
4-Pyrimidinecarboxamide, N-[(4-fluorophenyl-2,3,5,6-d4)methyl-d2]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo- 性質(zhì)
4-Pyrimidinecarboxamide, N-[(4-fluorophenyl-2,3,5,6-d4)methyl-d2]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo- 用途與合成方法
Raltegravir-d6是氘代標(biāo)記的Raltegravir。Raltegravir(MK0518)是HIV整合酶(IN)抑制劑。
![4-Pyrimidinecarboxamide, N-[(4-fluorophenyl-2,3,5,6-d4)methyl-d2]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo- 結(jié)構(gòu)式](CAS/20200401/GIF/1100750-98-8.gif)